TY - JOUR
T1 - TENDENCIAS EN EL USO DE FÁRMACOS PARA LA COVID-19 DURANTE LA PRIMERA OLA DE LA PANDEMIA EN UN HOSPITAL DE LIMA, PERÚ
AU - Castro, Nataly Echevarria
AU - García, Danitza Rojo
AU - Rivera, Midori Torpoco
AU - Rondán-Guerrero, Paola
AU - García-Rojas, Frank
AU - Taype-Rondan, Alvaro
N1 - Publisher Copyright:
© 2021, Instituto Nacional de Salud. All rights reserved.
PY - 2021
Y1 - 2021
N2 - This study aimed to evaluate the pharmacological trends in patients with COVID-19 from a hospital in Peru during the first wave of the pandemic. Retrospective study conducted between April and September 2020. The medical records of patients hospitalized for COVID-19 pneumonia at the Dos de Mayo National Hospital (Lima, Peru) were reviewed. Of a total of 3103 patients, 381 medical records were included (77.4% male, median age: 44 years). The use of four prehospital drugs increased (azithromycin, ivermectin, corticosteroids, and ceftriaxone), while the in-hospital use of six drugs (ceftriaxone, azithromycin, hydroxychloroquine, ivermectin, corticosteroid pulse, and prophylactic anticoagulation) decreased and in-hospital anticoagulation use decreased. These findings suggest that the management of COVID-19 has varied during the first wave of the pandemic, typically increasing prehospital drug use and decreasing inpatient use.
AB - This study aimed to evaluate the pharmacological trends in patients with COVID-19 from a hospital in Peru during the first wave of the pandemic. Retrospective study conducted between April and September 2020. The medical records of patients hospitalized for COVID-19 pneumonia at the Dos de Mayo National Hospital (Lima, Peru) were reviewed. Of a total of 3103 patients, 381 medical records were included (77.4% male, median age: 44 years). The use of four prehospital drugs increased (azithromycin, ivermectin, corticosteroids, and ceftriaxone), while the in-hospital use of six drugs (ceftriaxone, azithromycin, hydroxychloroquine, ivermectin, corticosteroid pulse, and prophylactic anticoagulation) decreased and in-hospital anticoagulation use decreased. These findings suggest that the management of COVID-19 has varied during the first wave of the pandemic, typically increasing prehospital drug use and decreasing inpatient use.
KW - Anti-bacterial Agents
KW - COVID-19
KW - Dexamethasone
KW - Drugs Utilization
KW - Epidemiologic Factors
KW - Hospitalization
KW - Peru
KW - Pneumonia
KW - Therapeutics
KW - Trends
UR - http://www.scopus.com/inward/record.url?scp=85124556574&partnerID=8YFLogxK
U2 - 10.17843/rpmesp.2021.384.8820
DO - 10.17843/rpmesp.2021.384.8820
M3 - Artículo
AN - SCOPUS:85124556574
SN - 1726-4634
VL - 38
SP - 608
EP - 614
JO - Revista Peruana de Medicina Experimental y Salud Publica
JF - Revista Peruana de Medicina Experimental y Salud Publica
IS - 4
ER -
